MISSHA VITA C plus Spot Correcting & Firming Ampoule 40ml
Description
It is your secret weapon for a brighter, firmer complexion.
This powerful formula is clinically proven to combat seven key signs of aging, delivering transformative results.
Featuring a potent 33% Vita C Liposome Formula, it encapsulates 99% pure Vitamin C and collagen in microcapsules.
This advanced delivery system quickly penetrates the skin, ensuring maximum efficacy for a revitalized look.
This “must-have” 2-in-1 wrinkle repair and brightening serum targets dark spots, discoloration, rough texture, and visible sagging.
It is specifically recommended for those with aging or dull skin and persistent dark spots, helping to restore a youthful radiance and improve skin’s overall firmness and texture.
It has been clinically proven to target: sun damage, aging spots, uneven skin tone, loss of elasticity, decreased intercellular lipids, rough texture, and loss of vitality.
Furthermore, this incredible ampoule has a skin-friendly pH of 6.2 and is consciously formulated without artificial fragrances, colors, parabens, sulfates, animal products, alcohol, or mineral oils, ensuring gentle yet effective care.
Feature
- Potent Formula: Contains 33% Vita C Liposome Formula with 99% pure Vitamin C and collagen microcapsules.
- 2-in-1 Benefits: Functions as a wrinkle repair and brightening serum.
- Targeted Action: Clinically proven to address seven signs of aging (sun damage, spots, uneven tone, elasticity loss, etc.).
- Clean Formulation: pH of 6.2; free from artificial fragrances, colors, parabens, sulfates, animal products, alcohol, and mineral oils.
- Recommended For: Aging or dull skin and dark spots.
How to use
- After cleansing, take a moderate amount.
- Apply following the skin’s natural texture in this order: Cheeks, Forehead, Neck.
- For blemish-prone spots or areas with loose skin—especially around the eyes, mouth, jaw, and C-zone—gently massage the ampoule into the skin, moving from the center of the face outwards.








Reviews
There are no reviews yet.